Literature DB >> 2408158

Some ras-transformed cells have increased radiosensitivity and decreased repair of sublethal radiation damage.

J F Harris1, A F Chambers, A S Tam.   

Abstract

We examined the effect of 60Co irradiation on the clonogenic survival of rat NRK cells, NRK cells carrying a temperature-sensitive viral K-ras oncogene (tsK-NRK), mouse NIH 3T3 cells, and NIH 3T3 cells transformed with the human bladder cancer (T24) H-ras oncogene (PAP2). We tested the hypothesis that ras oncogene expression renders cells more resistant to radiation, but found in both systems that ras-transformed cells were more, not less, sensitive to radiation. We also found indications of altered repair of sublethal radiation damage. PAP2 cells were more sensitive to radiation than NIH 3T3 cells. Increased sensitivity was reflected in a decreased shoulder region of the survival curve with little effect on its slope (D0). TsK-NRK cells were also slightly more sensitive to radiation than NRK and exhibited decreased repair of sublethal damage at both the permissive and nonpermissive temperatures. Thus, we found that expression of ras oncogenes is not always associated with increased radiation resistance. In summary, our results suggest that (1) ras oncogene expression in some cells may be associated with increased, rather than decreased, radiation sensitivity, and (2) ras oncogene expression may alter the shoulder region of the dose response curve, suggesting changes in the repair of sublethal radiation damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2408158     DOI: 10.1007/bf01650478

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  3 in total

1.  ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells.

Authors:  A B Tuck; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

2.  Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.

Authors:  R Kothapalli; N Guthrie; A F Chambers; K K Carroll
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

3.  The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution.

Authors:  Frédérique Mégnin-Chanet; François Lavelle; Vincent Favaudon
Journal:  BMC Pharmacol       Date:  2002-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.